Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

124
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
124
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

13.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
13.2K
Sensitivity, Specificity, and Predicted Value01:13

Sensitivity, Specificity, and Predicted Value

213
In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
213
  1. Home
  3. Research Domains
  5. Biological Sciences
  7. Genetics
  9. Epigenetics (incl. Genome Methylation And Epigenomics)
  11. A Systematic Evaluation Of The Performance And Properties Of The Uk Biobank Polygenic Risk Score (prs) Release

A systematic evaluation of the performance and properties of the UK Biobank Polygenic Risk Score (PRS) Release

Deborah J Thompson1, Daniel Wells1, Saskia Selzam1

  • 1Genomics plc, Oxford, United Kingdom.

Plos One
|September 18, 2024

Related Experiment Videos

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.0K
Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
09:38

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Published on: November 14, 2017

14.8K
Pooled CRISPR-Based Genetic Screens in Mammalian Cells
00:09

Pooled CRISPR-Based Genetic Screens in Mammalian Cells

Published on: September 4, 2019

21.8K

View abstract on PubMed

Summary
This summary is machine-generated.

The UK Biobank (UKB) Polygenic Risk Score (PRS) Release offers PRSs for 53 traits, outperforming 76 other PRSs. These validated PRSs show potential clinical benefit.

Area of Science:

  • Genetics
  • Bioinformatics
  • Epidemiology

Background:

  • Polygenic Risk Scores (PRS) are crucial for predicting disease risk.
  • Evaluating and benchmarking PRS performance is essential for clinical utility.
  • The UK Biobank (UKB) provides a valuable resource for genetic research.

Purpose of the Study:

  • To evaluate the UK Biobank (UKB) Polygenic Risk Score (PRS) Release for 28 diseases and 25 quantitative traits.
  • To develop a benchmarking software tool for standardized PRS performance evaluation.
  • To assess the potential clinical benefit of the UKB PRS Release.

Main Methods:

  • A unified pipeline was used for PRS evaluation across multiple traits.
  • Benchmarking software was developed for like-for-like comparison of different PRS.

Related Experiment Videos

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.0K
Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
09:38

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Published on: November 14, 2017

14.8K
Pooled CRISPR-Based Genetic Screens in Mammalian Cells
00:09

Pooled CRISPR-Based Genetic Screens in Mammalian Cells

Published on: September 4, 2019

21.8K
  • PRS algorithms were validated in an independent cohort (100,000 Genomes Project).

    • Main Results:

    • The UKB PRS Release demonstrated superior performance compared to 76 published PRSs.
    • PRS algorithms were validated for numerous diseases and traits in an independent cohort.
    • The availability of PRSs for 53 traits enabled systematic assessment of their properties.

    Conclusions:

    • The UKB PRS Release represents a significant advancement in PRS availability and performance.
    • The validated PRSs show increased power and potential for clinical application.
    • The developed benchmarking tool facilitates standardized PRS evaluation for future research.